Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D 1 receptors in ON bipolar cells of goldfish retina

Visual Neuroscience

Volumn 22, Issue 1, 2005, Pages 55-63

  Fan, Shim Fang ^a   Yazulla, Stephen ^a  

^a Stony Brook University   (United States)

Author keywords

Bipolar cells; Cannabinoid; Dopamine; Membrane currents; Retina

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CALCIUM; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; COBALT; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; PERTUSSIS TOXIN; POTASSIUM ION; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GOLDFISH; LIGHT; MEMBRANE CURRENT; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PROTEIN FUNCTION; RETINA; RETINA BIPOLAR GANGLION CELL; RETINA CONE; RETINA ROD; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; DOPAMINE; GOLDFISH; INTERNEURONS; MORPHOLINES; NAPHTHALENES; POTASSIUM CHANNELS, VOLTAGE-GATED; RECEPTOR, CANNABINOID, CB1; RECEPTORS, DOPAMINE D1; RETINA;

EID: 18744400508     PISSN: 09525238     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0952523805221089     Document Type: Article

References (70)

1. AMERI, A. (1999). The effects of cannabinoids on the brain. Progress in Neurobiology 58, 315-348.
2. 2 agonist in rats with unilateral lesions of the nigrostriatal pathway. Brain Research 691, 106-114.
3. ANDERSON, J.J., KASK, A.M. & CHASE, T.N. (1996). Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists. European Journal of Pharmacology 295, 163-168.
4. AYOUB, G.S. & MATTHEWS, G. (1992). Substance P modulates calcium current in retinal bipolar neurons. Visual Neuroscience 8, 539-544.
5. BIRCH, J., KOLLE, RU., KUNKEL, M., PAULUS, W. & UPADHYAY, P. (1998). Acquired colour deficiency in patients with Parkinson's disease. Vision Research 38, 3421-3426.
6. BODIS-WOLLNER, I. (1990). Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients. Trends in Neuroscience 13, 296-302.
7. BODIS-WOLLNER, I. (1997). Visual electrophysiology in Parkinson's disease: PERG, VEP and visual P300. Clinical Electroencephalography 28, 143-147.
8. BODIS-WOLLNER, I. & ANTAL, A. (1995). On the functional significance of primate retinal dopamine receptors. Journal of Neural Transmission Suppl. 45, 67-74.
9. BONHAUS, D.W., CHANG, L.K., KWAN, J. & MARTIN, G.R. (1998). Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonist: Evidence for agonist-specific trafficking of intracellular responses. Journal of Pharmacology and Experimental Therapeutics 287, 884-888.
10. 1 receptor. European Journal of Pharmacology 374, 445-455.
11. CHEER, J.F., KENDALL, D.A., MASON, R. & MARSDEN, C.A. (2003). Differential cannabinoid-induced electrophysiological effects in rat ventral tegmentum. Neuropharmacology 44, 633-641.
12. CONSROE, P., MUSTY, R., REIN, J., TILLERY, W. & PERTWEE, R.G. (1997). The perceived effects of smoked cannabis on patients with multiple sclerosis. European Neurology 38, 44-48.
13. DAWSON, W., JIMENEZ-ANTILLON, C.F., PEREZ, J.M. & ZESKIND, J.A. (1977). Marijuana and vision-after ten years' use in Costa Rica. Investigative Ophthalmology and Visual Science 16, 689-699.
14. DE PETROCELLIS, L.D., CASCIO, M.G. & DI MARZO, V. (2004). The endocannabinoid system: A general view and latest additions. British Journal of Pharmacology 141, 765-774.
15. DJAMGOZ, M.B.A. & WAGNER, H.-J. (1992). Invited review: Localization and function of dopamine in the adult vertebrate retina. Neurochemistry International 20, 139-191.
16. DOWLING, J.E. & EHINGER, B. (1978). The interplexiform cell system-I. Synapses of the dopaminergic neurons of the goldfish retina. Proceedings of the Royal Society B (London) 201, 7-26.
17. + currents in retinal bipolar cells by ascorbate Visual Neuroscience 16, 138-148.
18. K(V)) in retinal bipolar cells by ascorbate is mediated by dopamine D1 receptors. Visual Neuroscience 16, 923-931.
19. FAN, S.-F. & YAZULLA, S. (2003). Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 receptor agonist WIN 55212-2. Visual Neuroscience 20, 177-188.
20. FAN, S.-F. & YAZULLA, S. (2004). Inhibitory interaction of cannabinoid CB1 receptor and dopamine D2 receptor agonists on voltage-gated currents of goldfish cones. Visual Neuroscience 21, 69-79.
21. FENWICK, W.M., MARTY, A. & NEHER, E. (1982). A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. Journal of Physiology 331, 577-597.
22. FRENCH, E.D. (1997). delta9-Tetrahydrocannabinoid excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors. Neuroscience Letters 226, 159-162.
23. FRIDE, E. (2002). Endocannabinoids in the central nervous system-an overview. Prostaglandins Leukotrienes and Essential Fatty Acids 66, 221-233.
24. GESSA, G.L., MELIS, M., MUNTONI, A.L. & DIANA, M. (1998). Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. European Journal of Pharmacology 341, 39-44.
25. GLASER, S.T., STUDHOLME, K.M., FATADE, R., YAZULLA, S., ABUMRAD, N.A. & DEUTSCH, D.G. (2002). Is there an anandamide transporter. Burlington, VT, International Cannabinoid Research Society. 2002 Symposium on the Cannabinoids. Page 9. http://cannabinoidsociety.org/HTML/ICRS.2002.symposium.pdf.
26. s linkage to the CB1 receptor. Journal of Neuroscience 17, 5327-5333.
27. 9-THC in the rat. Neuropharmacology 17, 137-144.
28. GREENGARD, P., NAIRN, A.C., GIRAULT, J.-A., OUVMET, C.C., SNYDER, G.L., FISONE, G., ALLEN, P.B., FIENBERG, A. & NISHI, A. (1998). The DARPP-32/protein phospatase-1 cascade: A model for signal integration. Brain Research Reviews 26, 274-284.
29. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Archives 391, 85-100.
30. HARNOIS, C. & DI PAOLO, T. (1990). Decreased dopamine in the retinas of patients with Parkinson's disease. Investigative Ophthalmology and Visual Science 31, 2473-2475.
31. HEIDELBERGER, R. & MATTHEWS, G. (1992). Calcium influx and calcium current in single synaptic terminals of goldfish retinal bipolar neurons. Journal of Physiology (London) 447, 235-256.
32. 2+ responses in synaptic terminals of retinal bipolar neurons. Neuroreport 5, 729-732.
33. HERMANN, H., MARSICANO, G. & LUTZ, B. (2002). Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience 109, 451-460.
34. JOHNSON, J., CARAVELLI, M.L. & BRECHA, N.C. (2001). Somatostatin inhibits calcium influx into rat rod bipolar cell axonal terminals. Visual Neuroscience 18, 101-108.
35. JULIAN, M.D., MARTIN, A.B., CUELLAR, B., RODRIGUEZ, D.F., NAVARRO, M., MORATALLA, R. & GARCIA-SEGURA, L.M. (2003). Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia. Neuroscience 119, 309-318.
36. KIPLINGER, G.F., MANNO, J.E., RODDA, B.E. & FORNEY, R.B. (1971). Dose-response analysis of the effects of tetrahydrocannabinol in man. Clinical Pharmacology and Therapeutics 12, 650-657.
37. KIRSCH, M. & WAGNER, H.-J. (1989). Release pattern of endogenous dopamine in teleost retinae during light adaptation and pharmacological stimulation. Vision Research 29, 147-154.
38. KUPERSMITH, M.J., SHAKIN, E., SIEGEL, I.M. & LIEBERMAN, A.R. (1982). Visual system abnormalities in patients with Parkinson's disease. Archives Neurology 39, 284-286.
39. LANGHEINRICH, T., TEBARTZ VAN ELST, L., LAGREZE, W.A., BACH, M., LUCKING, V.H. & GREENLEE, M.W. (2000). Visual contrast response functions in Parkinson's disease: Evidence from electroretinograms, visually evoked potentials and psychophysics. Clinical Neurophysiology 111, 66-74.
40. MANEUF, Y.P. & BROTCHIE, J.M. (1997). Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices. British Journal of Pharmacology 120, 1397-1398.
41. MATSUDA, S., KANEMITSU, N., NAKAMURA, A., MIMURA, Y., UEDA, N., KURAHASHI, Y. & YAMAMOTO, S. (1997). Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues. Experimental Eye Research 64, 707-711.
42. 1 cannabinoid and dopamine receptors in the rat and monkey striatum. Neuropharmacology 40, 918-926.
43. MORA-FERRER, C., YAZULLA, S., STUDHOLME, K.M. & HAAK-FRENDSCHO, M. (1999). Dopamine D1-receptor immunolocalization in goldfish retina. Journal of Comparative Neurology 411, 705-741.
44. MULLER, T., KUHN, W., BUTTNER, T. & PRZUNTEK, H. (1999). Colour vision abnormalities and movement time in Parkinson's disease. European Journal of Neurology 6, 711-715.
45. 9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterations. Pharmacology, Biochemistry and Behavior 45, 291-298.
46. NAWY, S. & JAHR, C.E. (1990). Suppression by glutamate of cGMP-activated conductance in retinal bipolar cells. Nature 346, 269-271.
47. NAWY, S. & JAHR, C.E. (1991). cGMP-gated conductance in retinal bipolar cells is suppressed by the photoreceptor transmitter. Neuron 7, 677-683.
48. NGUYEN-LEGROS, J., HARNOIS, C., DI PAOLO, T. & SIMON, A. (1993). The retinal dopamine system in Parkinson's disease. Clinical Visual Science 8, 1-12.
49. PATEL, S. & HILLARD, C.J. (2003). Cannabinoid-induced Fos expression within A10 dopaminergic neurons. Brain Research 963, 15-25.
50. PETRUCCI, C., RESTA, V., FIENI, F., BIGIANI, A., & BAGNOLI, P. (2001). Modulation of potassium current and calcium influx by somatostatin in rod bipolar cells isolated from the rabbit retina via sst2 receptors. Naunyn-Schmiedebergs Archives of Pharmacology 363, 680-694.
51. PIERI, V., DIEDERICH, N.J., RAMAN, R. & GOETZ, C.G. (2000). Decreased color discrimination and contrast sensitivity in Parkinson's disease. Journal of the Neurological Sciences 172, 7-11.
52. RODNITZKY, R.L. (1998). Visual dysfunction in Parkinson's disease. Clinical Neuroscience 5, 102-106.
53. 1 dopamine receptors enhances (-)-11-hydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats. Neuroreport 5, 761-765.
54. RUSSO, E.B., MERZOUKI, A., MESA, J.M., FREY, K.A. & BACH, P.J. (2004). Cannabis improves night vision: A case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco. Journal of Ethnopharmacology 93, 99-104.
55. SANUDO-PENA, M.C., FORCE, M., TSOU, K., MILLER, A.S. & WALKER, J.M. (1998). Effects of intrastriatal cannabinoids on rotational behavior in rats: Interactions with the dopaminergic system. Synapse 30, 221-226.
56. SAVINAINEN, J.R. & LAITINEN, J.T. (2004). Detection of cannabinoid CB1, adenosine A1, muscarinic acetylcholine, and GABA(B) receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retina. Cell Molecular Neurobiology 24, 243-256.
57. SCHLICKER, E., TIMM, J. & GÖTHERT, M. (1996). Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn-Schmiedebergs Archives of Pharmacology 354, 791-795.
58. SHIELLS, R.A. & FALK, G. (1990). Glutamate receptors of rod bipolar cells are linked to a cyclic CMP cascade via a G-protein. Proceedings of the Royal Society B (London) 242, 91-94.
59. SHIRE, D., CALANDRA, B., BOUABOULA, M., BARTH, F., RINALDE-CARMONA, M., CASELLAS, P. & FERRARA, P. (1999). Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Science 65, 627-635.
60. SNELLMAN, J. & NAWY, S. (2004). cGMP-dependent kinase regulates response sensitivity of the mouse on bipolar cell. Journal of Neuroscience 24, 6621-6628.
61. STRAIKER, A., STELLA, N., PIOMELLI, D., MACKIE, K., KARTEN, H.J. & MAGUIRE, G. (1999). Cannabinoid CB1 receptors and ligands in vertebrate retina: Localization and function of an endogenous signaling system. Proceedings of the National Academy of Sciences of the U.S.A. 96, 14565-14570.
62. STRAIKER, A. & SULLIVAN, J.M. (2003). Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander. Journal of Neurophysiology 89, 2647-2654.
63. TACHIBANA, M., OKADA, T., ARIMURA, T., KOBAYASHI, K. & PICCOLINO, M. (1993). Dihydropyridine-sensitive calcium current mediates neurotransmitter release from bipolar cells of the goldfish retina. Journal of Neuroscience 13, 2898-2909.
64. THORESON, W.B. & WITKOVSKY, P. (1999). Glutamate receptors and circuits in the vertebrate retina. Progress in Retinal and Eye Research 18, 765-810.
65. WITKOVSKY, P., NICHOLSON, C., RICE, M.E., BOHMAKER, K. & MELLER, E. (1993). Extracellular dopamine concentration in the retina of the clawed frog, Xenopus laevis. Proceedings of the National Academy of Science of the U.S.A. 90, 5667-5671.
66. WOOLVERTON, W.L, & KLEVEN, M.S. (1988). Multiple dopamine receptors and the behavioral effects of cocaine. National Institute on Drug Abuse Research Monograph 88, 160-184.
67. 3H-GABA from goldfish retina in the dark. Brain Research 325, 171-180.
68. 3H- spiperone binding sites in the goldfish retina. Vision Research 35, 2509-2514.
69. YAZULLA, S., STUDHOLME, K.M., MCINTOSH, H.H. & DEUTSCH, D.G. (1999). Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina. Journal of Comparative Neurology 415, 80-90.
70. YAZULLA, S., STUDHOLME, K.M., MCINTOSH, H.H. & FAN, S.F. (2000). Cannabinoid receptors on goldfish retinal bipolar cells: Electron-microscope immunocytochemistry and whole-cell recordings. Visual Neuroscience 17, 391-401.